Her work regularly appears in The New York T...
IGF-1 LR3 has a longer half-life compared to the base form of IGF-1, allowing for a longer duration of activity in the body
Always discuss your treatment goals with your clinician, especially if youre using a GLP-1 to manage menopause-related weight changes
Your doctor may need to adjust doses of these medications to reduce hypoglycaemia risk and improve sleep quality
The following risk considerations are precautionary in nature, reflecting general clinical principles rather than retatrutide-specific evidence
Maass A, Duzel S, Brigadski T, Goerke M, Becke A, Sobieray U, Neumann K, Lovden M, Lindenberger U, Backman L, Braun-Dullaeus R, Ahrens D, Heinze HJ, Muller NG, Lessmann V, Sendtner M, Duzel E